Koo Foundation Sun Yet-Sen Cancer Center

Taipei 112

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Studies at this site

• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment — Completed
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy — Completed